A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales

OBJECTIVES: COVID-19 is associated with significant morbidity and mortality. This study aims to synthesize evidence to assess the cost-effectiveness of remdesivir (RDV) for the treatment of hospitalized patients with COVID-19 in England and Wales. METHODS: A probabilistic cost-effectiveness analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafia, Rachid, Martyn-St James, Marrissa, Harnan, Sue, Metry, Andrew, Hamilton, Jean, Wailoo, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc. 2022
Materias:
Themed Section: COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858417/
https://www.ncbi.nlm.nih.gov/pubmed/35197225
http://dx.doi.org/10.1016/j.jval.2021.12.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858417/
https://www.ncbi.nlm.nih.gov/pubmed/35197225
http://dx.doi.org/10.1016/j.jval.2021.12.015

Ejemplares similares